tiprankstipranks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market
TRDA
Entrada Therapeutics Inc
RESEARCH TOOLSreports
Want to see TRDA full AI Analyst Report?

Entrada Therapeutics Inc (TRDA) Financial Statements

149 Followers

Entrada Therapeutics Inc Financial Overview

Entrada Therapeutics Inc's market cap is currently $524.08M. The company's EPS TTM is $-0.94; its P/E ratio is -2.96; Entrada Therapeutics Inc is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $-1.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 25.42M$ 210.78M$ 129.01M$ 0.00$ 0.00
Gross Profit$ 21.32M$ 210.78M$ 129.01M$ 0.00$ 0.00
Operating Income$ -156.00M$ 47.01M$ -3.16M$ -97.25M$ -51.13M
EBITDA$ -142.40M$ 47.01M$ -321.00K$ -95.35M$ -50.01M
Net Income$ -143.75M$ 65.63M$ -6.68M$ -94.62M$ -51.16M
Balance Sheet
Cash & Short-Term Investments$ 295.70M$ 420.00M$ 351.97M$ 188.71M$ 291.06M
Total Assets$ 377.38M$ 526.32M$ 469.19M$ 252.06M$ 305.83M
Total Debt$ 50.93M$ 59.21M$ 68.23M$ 25.94M$ 0.00
Net Debt$ -39.46M$ -42.00M$ 628.00K$ -19.22M$ -291.06M
Total Liabilities$ 71.25M$ 97.64M$ 226.83M$ 39.50M$ 7.12M
Stockholders' Equity$ 306.13M$ 428.68M$ 242.36M$ 212.55M$ 298.72M
Cash Flow
Free Cash Flow$ -129.55M$ -44.72M$ 134.19M$ -96.67M$ -55.44M
Operating Cash Flow$ -128.51M$ -41.56M$ 139.80M$ -93.79M$ -50.86M
Investing Cash Flow$ 116.81M$ -27.80M$ -138.40M$ -148.65M$ -4.58M
Financing Cash Flow$ 887.00K$ 102.96M$ 21.04M$ 479.00K$ 307.46M
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

Income Statement >

Entrada Therapeutics Inc Debt to Assets

Balance Sheet >

Entrada Therapeutics Inc Cash Flow

Cash Flow >

Entrada Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >